Hormone Replacement Therapy (HRT) Market research report by Delvens focuses on primary sections such as – market segments, market outlook, competitive landscape, and company profiles. The segments provide details in terms of various perspectives such as end-use industry, product or service type, and any other relevant segmentation as per the market’s current scenario which includes various aspects to perform further marketing activity.
The global Hormone Replacement Therapy (HRT) Market size is projected to reach a CAGR of 6.3% from 2023-2030.
Get Free Sample Report: https://www.delvens.com/get-free-sample/hormone-replacement-therapy-hrt-market
Hormone replacement therapy is used when the human body is not able to produce enough hormones. It is used for the treatment of menopause, hypothyroidism, male hypogonadism, and growth hormone deficiency conditions. The signs that the individual requires hormone replacement therapy are hot flashes, night sweats, vaginal dryness, pain, itching, or burning during intercourse, bone loss, low sex drive, mood changes, and irritability.
The increasing prevalence of chronic conditions such as hypogonadism in adult men worldwide is expected to drive the growth of the hormone replacement therapy market. Furthermore, another major factor fuelling the growth of the market is the ease of access to hormonal replacement therapy and government support for research and development activities for hormonal replacement therapy drugs.
Key Findings:
• The product segment is further fragmented into Estrogen and Progesterone Replacement Therapy, Human Growth Hormone (HGH) Replacement Therapy, Thyroid Hormone Replacement Therapy, Testosterone Replacement Therapy, and Parathyroid Hormone Replacement.
• The route of administration segment is further fragmented into Oral, Parenteral, Transdermal, and Others. The oral segment dominated the market due to the high prescription rate and ease of administration.
• The disease segment is further fragmented into Menopause, Hypothyroidism, Male Hypogonadism, Growth Hormone Deficiency, and Hypoparathyroidism.
Competitive Landscape
• Novartis AG
• Abbott Laboratories
• Mylan N.V.
• Merck KgaA
• Bayer AG
• Pfizer Inc.
• Novo Nordisk A/S
• QuatRx Pharmaceuticals
• Teva Pharmaceutical Industries Ltd.
• Amgen, Inc.
• Eli Lilly and Company
For More Inquiry Contact us: https://www.delvens.com/Inquire-before-buying/hormone-replacement-therapy-hrt-market
The Report helps to identify the opportunities in Global Regions:
• North America (the United States, Canada, and Mexico)
• Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
• Asia-Pacific (China, Japan, Korea, India, Australia, and Southeast Asia (Indonesia, Thailand, Philippines, Malaysia, and Vietnam))
• South America (Brazil etc.)
• The Middle East and Africa (North Africa and GCC Countries)
Recent Developments
• May 2021 – Myovant Sciences GmbH announced that it received approval from the U.S. FDA for its hormone therapy Myfembree as a treatment for uterine fibroid bleeding. The drug launched by Myovant will give direct competition to AbbVie with an added dosing advantage.
• April 2021 – TherapeuticsMD, Inc. and Theramex announced that they received approval from the Medicines and Healthcare Products Regulatory Agency (MHRA) and Federal Agency of Medicines and Health Products (FAMHP) for the use of BIJUVE in the U.K and under BIJUVA trade name in Belgium. The capsule will be used as hormone replacement therapy.
Reasons to Acquire
Increase your understanding of the market for identifying the best and most suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends, and factors.
Gain authentic and granular data access for Hormone Replacement Therapy Market so as to understand the trends and the factors involved in changing market situations.
Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future.
In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns.
Access Full Report: https://www.delvens.com/report/hormone-replacement-therapy-hrt-market
In addition to the market data for the Hormone Replacement Therapy Market, Delvens offers client-centric reports customized according to the company’s specific demand and requirements.
More Reports from Delvens:
Pendred Syndrome (PS) market size was estimated at USD 2.82 billion in 2023 and is projected to reach USD 3.83 billion in 2030 at a CAGR of 4.5% during the forecast period 2023-2030.
Multiple Sclerosis (MS) market size was estimated at USD 25.2 billion in 2023 and is projected to reach USD 34.9 billion in 2030 at a CAGR of 4.76% during the forecast period 2023-2030.
Plastic Surgery and Integumentary System Market size was estimated at USD 3.02 billion in 2023 and is projected to reach USD 4.3 billion in 2030 at a CAGR of 5.2% during the forecast period 2023-2030.
About Us:
Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.
Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.
Contact us:
UNIT NO. 2126, TOWER B,
21ST FLOOR ALPHATHUM
SECTOR 90 NOIDA 201305, IN
+44-20-3290-6466
+1 214-377-1144
[email protected]